Division of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Department of Biostatistics and.
Ann Am Thorac Soc. 2024 Mar;21(3):421-427. doi: 10.1513/AnnalsATS.202209-751OC.
Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are detrimental events in the natural history of COPD, but the risk factors associated with future exacerbations in the absence of a history of recent exacerbations are not fully understood. To identify risk factors for COPD exacerbations among participants in the Genetic Epidemiology of COPD Study (COPDGene) without a history of exacerbation in the previous year. We identified participants with a smoking history enrolled in COPDGene who had COPD (defined as forced expiratory volume in 1 second [FEV]/forced vital capacity < 0.70), no exacerbation in the year before their second study site visit, and who completed at least one longitudinal follow-up questionnaire in the following 36 months. We used univariable and multivariable zero-inflated negative binomial regression models to identify risk factors associated with increased rates of exacerbation. Each risk factor's regression coefficient (β) was rounded to the nearest 0.25 and incorporated into a graduated risk score. Among the 1,528 participants with a smoking history and COPD enrolled in COPDGene without exacerbation in the year before their second study site visit, 508 participants (33.2%) had at least one moderate or severe exacerbation in the 36 months studied. Gastroesophageal reflux disease, chronic bronchitis, high symptom burden (as measured by Modified Medical Research Council Dyspnea Scale and COPD Assessment Test), and lower FEV% predicted were associated with an increased risk of exacerbation. Each 1-point increase in our graduated risk score was associated with a 25-30% increase in exacerbation rate in the 36 months studied. In patients with COPD without a recent history of exacerbations, gastroesophageal reflux disease, chronic bronchitis, high symptom burden, and lower lung function are associated with increased risk of future exacerbation using a simple risk score that can be used in clinical practice.
慢性阻塞性肺疾病(COPD)的急性加重(AE-COPD)是 COPD 自然病程中的不利事件,但对于没有近期加重史的患者,与未来加重相关的危险因素尚不完全清楚。本研究旨在确定 COPD 基因研究(COPDGene)中既往 1 年无加重史的患者发生 COPD 加重的危险因素。
我们确定了 COPDGene 研究中具有吸烟史且符合以下条件的参与者:用力呼气量 1 秒(FEV1)/用力肺活量(FVC)<0.70 定义为 COPD,在第二次研究访视前 1 年内无加重史,且在随后的 36 个月内至少完成 1 次纵向随访问卷。我们采用单变量和多变量零膨胀负二项回归模型来确定与加重率增加相关的危险因素。每个危险因素的回归系数(β)四舍五入到最接近的 0.25,并纳入分级风险评分。
在 COPDGene 中,1528 名有吸烟史且符合 COPD 诊断标准且在第二次研究访视前 1 年内无加重史的患者中,508 名(33.2%)患者在研究的 36 个月内至少发生了 1 次中重度加重。胃食管反流病、慢性支气管炎、高症状负担(采用改良医学研究理事会呼吸困难量表和 COPD 评估测试进行评估)和较低的 FEV1%预计值与加重风险增加相关。我们的分级风险评分每增加 1 分,在研究的 36 个月内,加重率增加 25-30%。
在既往无近期加重史的 COPD 患者中,胃食管反流病、慢性支气管炎、高症状负担和较低的肺功能与未来加重风险增加相关,可使用简单的风险评分进行评估,该评分可用于临床实践。